ask="N/A"
ask_size="N/A"
average_daily_volume="524879"
bid="53.00"
bid_size="300"
book_value="11.13"
change="+1.34"
change_from_200_day_moving_average="8.47"
change_from_50_day_moving_average="3.79"
change_from_52_week_high="-2.12"
change_From_52_week_low="28.05"
change_in_percent="+2.53%"
close="54.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.20"
ebitda="-132.17M"
eps_estimate_current_year="-4.37"
eps_estimate_next_quarter="-1.25"
eps_estimate_next_year="-5.21"
ex_dividend_date="N/A"
float_shares="33657000"
high="55.16"
high_52_weeks="56.45"
last_trade_date="2/14/2017"
last_trade_price="54.33"
last_trade_size="22683"
last_trade_time="4:00pm"
low="53.00"
low_52_weeks="26.28"
market_capitalization="2.02B"
moving_average_200_day="45.86"
moving_average_50_day="50.54"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="75.27"
open="53.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+18.48%"
percent_change_from_50_day_moving_average="+7.49%"
percent_change_from_52_week_high="-3.76%"
percent_change_from_52_week_low="+106.73%"
previous_close="52.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.76"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37167000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="980151"
weeks_range_52="26.28 - 56.45"
